Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating botulinum toxin type A for treatment of facial lines including crow's feet and glabellar lines; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crow Feet Lines
• Facial Rhytides
• Glabellar Lines

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Facial Rhytides, Crow's Feet Lines | Phase 3 | Status: COMPLETED | Results posted: 2013-12-03